{{Rsnum
|rsid=12310399
|Gene=FGD6
|Chromosome=12
|position=95096472
|Orientation=plus
|GMAF=0.3806
|Gene_s=FGD6
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.5 | 40.7 | 39.8
| HCB | 10.3 | 52.9 | 36.8
| JPT | 15.0 | 46.0 | 38.9
| YRI | 23.1 | 47.6 | 29.3
| ASW | 28.1 | 50.9 | 21.1
| CHB | 10.3 | 52.9 | 36.8
| CHD | 8.3 | 47.7 | 44.0
| GIH | 9.9 | 50.5 | 39.6
| LWK | 22.7 | 47.3 | 30.0
| MEX | 22.4 | 50.0 | 27.6
| MKK | 31.6 | 43.9 | 24.5
| TSI | 11.8 | 49.0 | 39.2
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=2E-7
  |OR=1.85
  |ORtxt=[1.329-2.58]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}